Fear of hypoglycemia (FOH) is a significant yet often overlooked issue for elderly patients with type 2 diabetes. This fear not only affects their psychological well-being but also has a detrimental impact on their metabolic control. While research on FOH in type 2 diabetes patients is limited, this study aims to delve into the current status and influencing factors of FOH in elderly patients, specifically exploring the roles of cognitive fusion and self-care activities.
The study, conducted from November 2023 to October 2024, involved 200 elderly patients with type 2 diabetes admitted to the endocrinology department of two tertiary hospitals in Zhengzhou. The results revealed that FOH is a prevalent concern among these patients, with a total score of (25.81 ± 10.81). Interestingly, factors such as age, the number of hypoglycemic episodes, medical payment methods (free medical service/self-pay), cognitive fusion, and self-care activities were identified as significant influencers of FOH.
The path factor model further highlighted that age, self-pay, free medical service, the number of hypoglycemic episodes, cognitive fusion, and self-care activities directly affect FOH. Additionally, age, self-pay, the number of hypoglycemic episodes, and cognitive fusion had notable indirect effects on FOH, with cognitive fusion ranking first among the total effects.
These findings emphasize the multifaceted nature of FOH in elderly type 2 diabetes patients. Healthcare professionals must strike a balance between glycemic targets and patients' psychological burden. Developing preventive interventions for hypoglycemia should focus on effectively reducing risk while minimizing potential anxiety in this vulnerable population.
The study's implications are far-reaching, highlighting the need for a comprehensive approach to diabetes management that considers both physical and psychological aspects. By understanding the complex interplay between FOH, cognitive fusion, and self-care activities, healthcare providers can tailor interventions to improve the overall well-being and quality of life for elderly type 2 diabetes patients.
